These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16260919)

  • 21. Profile of HIV associated tuberculosis at a tertiary institute in setting of free anti-retroviral therapy.
    Agarwal U; Kumar A; Behera D
    J Assoc Physicians India; 2009 Oct; 57():685-90. PubMed ID: 20329424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infection.
    Dheda K; Chang JS; Breen RA; Haddock JA; Lipman MC; Kim LU; Huggett JF; Johnson MA; Rook GA; Zumla A
    AIDS; 2005 Oct; 19(15):1601-6. PubMed ID: 16184029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The imaging spectrum of pulmonary tuberculosis in AIDS.
    Saurborn DP; Fishman JE; Boiselle PM
    J Thorac Imaging; 2002 Jan; 17(1):28-33. PubMed ID: 11828209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic necrotizing pulmonary aspergillosis after tuberculosis in an HIV-positive woman: an unusual immune reconstitution phenomenon?
    Hasse B; Strebel B; Thurnheer R; Uhlmann F; Krause M
    AIDS; 2005 Dec; 19(18):2179-81. PubMed ID: 16284474
    [No Abstract]   [Full Text] [Related]  

  • 25. The immune reconstitution inflammatory syndrome with tuberculosis: a common problem in Ethiopian HIV-infected patients beginning antiretroviral therapy.
    Ali K; Klotz SA
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(3):198-202. PubMed ID: 21521804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is antimicrobial multiresistance to antibiotics in Cambodian HIV-positive children related to prior antiretroviral or tuberculosis chemotherapy?
    Docze A; Benca G; Augustin A; Liska A; Beno P; Babela O; Krcmery V
    Scand J Infect Dis; 2004; 36(10):779-80. PubMed ID: 15513413
    [No Abstract]   [Full Text] [Related]  

  • 27. Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy.
    Breen RA; Miller RF; Gorsuch T; Smith CJ; Ainsworth J; Ballinger J; Swaden L; Cropley I; Johnson MA; Lipman MC
    J Infect Dis; 2006 May; 193(10):1437-40. PubMed ID: 16619192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A delayed immune reconstitution inflammatory syndrome.
    Cailhol J; Pizzocolo C; Brauner M; Bouchaud O; Abgrall S
    AIDS; 2007 Jan; 21(1):115-6. PubMed ID: 17148980
    [No Abstract]   [Full Text] [Related]  

  • 29. [Tuberculosis and nontuberculous mycobacterial infections].
    Wagner D; Kern WV
    Dtsch Med Wochenschr; 2011 Apr; 136(14):691-4. PubMed ID: 21448828
    [No Abstract]   [Full Text] [Related]  

  • 30. Highly active antiretroviral therapy for patients with tuberculosis: the solution or the problem?
    Boix V; Merino E; Portilla J
    AIDS; 2002 Jul; 16(10):1436-7. PubMed ID: 12131228
    [No Abstract]   [Full Text] [Related]  

  • 31. Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy.
    Buckingham SJ; Haddow LJ; Shaw PJ; Miller RF
    Clin Radiol; 2004 Jun; 59(6):505-13. PubMed ID: 15145720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An AIDS patient with immune reconstitution inflammatory syndrome due to pulmonary Mycobacterium kansasii infection during antiretroviral therapy.
    Ito M; Komatsu Y; Ushiki A; Yamazaki Y; Kubo K
    J Infect Chemother; 2009 Oct; 15(5):331-4. PubMed ID: 19856074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis and HIV infection.
    John TJ; Kaur A; Babu PG
    Lancet; 1993 Sep; 342(8872):676. PubMed ID: 8103156
    [No Abstract]   [Full Text] [Related]  

  • 34. Opportunistic infections in the era of highly active antiretroviral therapy.
    Ferri RS
    Lippincotts Prim Care Pract; 2000; 4(1):20-8. PubMed ID: 11022517
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings.
    Harries AD; Chimzizi R; Zachariah R
    Lancet; 2006 Mar; 367(9514):944-5. PubMed ID: 16546545
    [No Abstract]   [Full Text] [Related]  

  • 36. Local immune responses correlate with presentation and outcome in tuberculosis.
    Condos R; Rom WN; Liu YM; Schluger NW
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):729-35. PubMed ID: 9517583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case records of the Massachusetts General Hospital. Case 18-2009. A 24-year-old woman with AIDS and tuberculosis with progressive cough, dyspnea, and wasting.
    Wilson D; Hurtado RM; Digumarthy S
    N Engl J Med; 2009 Jun; 360(23):2456-64. PubMed ID: 19494222
    [No Abstract]   [Full Text] [Related]  

  • 38. Mycobacterium avium brain abscess at the initiation of highly active antiretroviral therapy.
    Berger P; Lepidi H; Drogoul-Vey MP; Poizot-Martin I; Drancourt M
    Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):142-4. PubMed ID: 14689317
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune reconstitution eosinophilia due to schistosomiasis.
    Fernando R; Miller R
    Sex Transm Infect; 2002 Feb; 78(1):76. PubMed ID: 11872878
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of tuberculosis in the HIV-infected patient.
    Sterling TR
    Hopkins HIV Rep; 2003 Mar; 15(2):3. PubMed ID: 12739499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.